Allergan buys toxin delivery tech firm, boosts Botox portfolio
Allergan has acquired neurotoxin company Anterios for $90m (€83m).
Archives for January 11, 2016
AMRI's Burlington to produce cancer drug in JV with Eagle
A chemotherapy drug marketed by Eagle Pharmaceuticals has become the first product approved for commercial manufacture from AMRI’s once troubled Burlington facility.
With WIL, Charles River to expand client’s research efforts
Charles River is set to acquire WIL Research for approximately $585 million in cash, further enhancing the company’s capabilities to include contract development and manufacturing (CDMO).
Fresenius Kabi moves into prefilled syringe space through BD Rx buy
Fresenius Kabi has moved into the prefilled syringe space by acquiring Becton, Dickinson and Company’s injectables business and US manufacturing plant.